224 related articles for article (PubMed ID: 18928601)
1. [Expression of tumor suppressor gene pten in patients with myelodysplastic syndrome and acute myeloid leukemia].
Zou XL; Liu T; Meng WT; Huang XO
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1086-90. PubMed ID: 18928601
[TBL] [Abstract][Full Text] [Related]
2. [Expression of WT1 gene in patients with myelodysplastic syndrome and acute leukemia].
Lu Y; Jin J; Xu WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):464-6. PubMed ID: 15363132
[TBL] [Abstract][Full Text] [Related]
3. [The correlation study of PTEN gene expression and Akt phosphorylation in myelodysplastic syndrome].
Chen BG; Zhu M; Luo WD; Yan WH; Zhou MY; Li BL; Tao DD
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):470-3. PubMed ID: 18072631
[TBL] [Abstract][Full Text] [Related]
4. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
[TBL] [Abstract][Full Text] [Related]
5. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
[TBL] [Abstract][Full Text] [Related]
6. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances].
Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824
[TBL] [Abstract][Full Text] [Related]
7. [Effects of uroacitides on the methylation of PTEN gene in myelodysplastic syndrome cells and its mechanism].
Huang J; Yang M; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):600-5. PubMed ID: 23906454
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
9. [Expression of cell cycle control genes in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
[TBL] [Abstract][Full Text] [Related]
11. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia].
Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720
[TBL] [Abstract][Full Text] [Related]
12. [Expression of insulin-like growth factor receptor type I in marrow nucleated cells from hematologic malignancies and its anti-apoptotic effect].
He Q; Li X; Tao Y; Liu YZ; Yang LP; Ying SX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):483-7. PubMed ID: 15972147
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of expression of PTEN with AKT phosphorylation level in leukemia cells].
Zhang YY; Liu T; Meng WT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1109-13. PubMed ID: 21129241
[TBL] [Abstract][Full Text] [Related]
14. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
[TBL] [Abstract][Full Text] [Related]
15. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
16. MN1 and PTEN gene expression in acute myeloid leukemia.
Zayed RA; Eltaweel MA; Botros SK; Zaki MA
Cancer Biomark; 2017; 18(2):177-182. PubMed ID: 27983532
[TBL] [Abstract][Full Text] [Related]
17. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
[TBL] [Abstract][Full Text] [Related]
18. [Study on expression of Evi1 and MDS1-Evi1 genes in myelodysplastic syndromes].
Xu K; Wang L; Hao Y
Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):315-9. PubMed ID: 11243114
[TBL] [Abstract][Full Text] [Related]
19. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Peng J; Tang G; Goswami M; Young KH; Singh R; Medeiros LJ; Kantarjian HM; Luthra R; Wang SA
J Hematol Oncol; 2015 May; 8():45. PubMed ID: 25952993
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
de Melo Campos P; Traina F; da Silva Santos Duarte A; Lorand-Metze I; Costa FF; Saad ST
Leuk Res; 2007 Jun; 31(6):853-7. PubMed ID: 17270269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
